statistiche ricercatore

Continente	#
NA - Nord America	809
AS - Asia	303
EU - Europa	275
SA - Sud America	54
AF - Africa	5
Continente sconosciuto - Info sul continente non disponibili	2
Totale	1.448

Nazione	#
US - Stati Uniti d'America	791
SG - Singapore	115
CN - Cina	86
GB - Regno Unito	80
SE - Svezia	47
DE - Germania	43
HK - Hong Kong	43
BR - Brasile	42
VN - Vietnam	31
IT - Italia	29
RU - Federazione Russa	18
FI - Finlandia	10
FR - Francia	10
LT - Lituania	8
MX - Messico	8
AR - Argentina	7
BE - Belgio	7
BG - Bulgaria	7
IN - India	7
CA - Canada	6
UA - Ucraina	5
AT - Austria	4
ID - Indonesia	3
IQ - Iraq	3
KR - Corea	3
PK - Pakistan	3
PL - Polonia	3
BD - Bangladesh	2
JP - Giappone	2
NL - Olanda	2
VE - Venezuela	2
ZA - Sudafrica	2
A2 - ???statistics.table.value.countryCode.A2???	1
BO - Bolivia	1
CO - Colombia	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EG - Egitto	1
EU - Europa	1
GT - Guatemala	1
IE - Irlanda	1
JM - Giamaica	1
KG - Kirghizistan	1
MA - Marocco	1
MY - Malesia	1
PA - Panama	1
PE - Perù	1
RO - Romania	1
SA - Arabia Saudita	1
TR - Turchia	1
UZ - Uzbekistan	1
Totale	1.448

Nome	#
Physician–patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy	217
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients	205
Improving the disease awareness: how a communication campaign brings hidradenitis suppurativa to the light	198
Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience	189
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study	186
Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates – Italian Registry Hidradenitis Suppurativa project 2	174
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis	160
Advances in ultrafast plasmonics	134
Totale	1.463

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	107	0	0	0	0	0	10	20	12	20	22	14	9
2021/2022	179	6	9	10	12	3	23	1	8	16	10	64	17
2022/2023	151	20	23	10	19	24	17	2	8	11	3	5	9
2023/2024	92	2	1	11	17	17	4	17	5	2	1	11	4
2024/2025	351	10	3	4	42	67	48	23	23	40	23	30	38
2025/2026	267	52	21	33	52	96	13	0	0	0	0	0	0
Totale													1.463